The pharmaceutical market in India is one of the most-watched markets for emerging opportunities in areas like consumer healthcare drugs, biologics, vaccines and more. In fact, according to a recent CII-PwC report, India is projected to be among top 10 pharmaceutical markets globally by 2020. The report also showed that the industry in India has the potential to grow at an accelerated 15-20 percent CAGR for the next 10 years. To ensure the company stays up to date with industry needs and demands, SHL will speak and exhibit at the upcoming BioPharma India Convention 2012 from 26 to 27 November, an event that will allow pharmaceutical companies locally and globally to come together to assess the latest market trends and potential partnerships.
Marketing Director Steven Kaufman, who will speak at the event on the topic of Auto Injectors comments; "While we’ve already been speaking with several major Indian pharmaceutical companies, this will be the first time for SHL to actually attend and speak at an event taking place in India. This event will be a great opportunity for us to meet with the industry leaders in person and to better understand the real trends and needs of companies from India. Exhibiting at the show also allows us to provide hands-on device demos for potential prospects and introduce to them some of the proven technologies SHL has already brought to the same market in other regions. As several India-based biopharmaceutical companies are quite active in the area of biologics, the demand for information about drug delivery devices is steadily increasing. We look forward to having face-to-face meetings in Mumbai during this event and answering related questions."
SHL will be exhibiting at Booth # 9.